The Oklahoma Medical Research Foundation has named eight state science teachers as 2007 Foundation Scholars. The teachers, all middle- and high school instructors, were selected from a statewide applicant pool and will participate in “Biology is a Village,” a blended discussion and hands-on laboratory class at OMRF. They will receive a $2,000 stipend and $1,000 […]
News
OMRF names new development and planned giving director
The Oklahoma Medical Research Foundation announced today that it has named Laura Lang director of development and planned giving. Lang comes to OMRF with 11 years of dedicated service in the nonprofit sector. Most recently, she served as director of development for the Boys & Girls Clubs of Oklahoma County. She also was recruited by […]
Go nuts: New study shows that pistachios lower cholesterol
Good news for nut lovers: A new study from researchers at Penn State University and OMRF shows that modest intake of pistachios lowers cholesterol levels. The researchers also found that a small daily serving of the nuts provides antioxidants normally found in fruits and vegetables. The findings were presented at the Experimental Biology meeting this […]
Preserving genetic blueprints: OMRF researchers discover process that may prevent chromosomal abnormalities
Researchers discover process that may prevent chromosomal abnormalities
OMRF to honor scientists, board member
The Oklahoma Medical Research Foundation will honor a pair of scientists and a board member at its annual honors and awards banquet Tuesday. For the first time in OMRF’s 61-year history, the event will be held in Tulsa, at historic Cain’s Ballroom. OMRF will award Linda Thompson, Ph.D., the Edward L. and Thelma Gaylord Prize […]
FDA approves Protein C deficiency drug with OMRF roots
The U.S. Food and Drug Administration (FDA) has approved a new drug that has its origins at the Oklahoma Medical Research Foundation as the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder. The drug is a treatment for patients with complications related to severe congenital […]
